|
PARD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59870000004947E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.49179999999894E-05 |
| Normal-vs-Stage2 |
2.790300E-02 |
| Normal-vs-Stage3 |
7.14979999982823E-07 |
| Normal-vs-Stage4 |
1.138050E-02 |
| Stage1-vs-Stage2 |
9.999200E-01 |
| Stage1-vs-Stage3 |
3.455900E-02 |
| Stage1-vs-Stage4 |
9.965400E-01 |
| Stage2-vs-Stage3 |
1.840570E-01 |
| Stage2-vs-Stage4 |
9.975400E-01 |
| Stage3-vs-Stage4 |
1.364400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52300000000327E-06 |
| Normal-vs-AfricanAmerican |
7.9801000000046E-05 |
| Normal-vs-Asian |
4.871000E-01 |
| Caucasian-vs-AfricanAmerican |
4.793400E-01 |
| Caucasian-vs-Asian |
1.974550E-01 |
| AfricanAmerican-vs-Asian |
1.638550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.22759999948907E-07 |
| Normal-vs-Female |
2.098000E-03 |
| Male-vs-Female |
1.033830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.311380E-01 |
| Normal-vs-Age(41-60Yrs) |
5.72019999999229E-05 |
| Normal-vs-Age(61-80Yrs) |
1.76481999999423E-05 |
| Normal-vs-Age(81-100Yrs) |
1.008440E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.704000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.357400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.045400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.631200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.991800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.364400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.576800E-01 |
| Normal-vs-Grade 2 |
1.193650E-04 |
| Normal-vs-Grade 3 |
1.6745299999954E-05 |
| Normal-vs-Grade 4 |
1.442360E-03 |
| Grade 1-vs-Grade 2 |
4.151600E-01 |
| Grade 1-vs-Grade 3 |
3.109400E-01 |
| Grade 1-vs-Grade 4 |
3.375000E-01 |
| Grade 2-vs-Grade 3 |
3.246200E-01 |
| Grade 2-vs-Grade 4 |
4.087800E-01 |
| Grade 3-vs-Grade 4 |
8.337200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.770500E-04 |
| Normal-vs-ccB subtype |
9.85430000000065E-05 |
| ccA subtype-vs-ccB subtype |
2.884200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.92629999998351E-06 |
| Normal-vs-N1 |
5.306400E-01 |
| N0-vs-N1 |
6.479900E-02 |
|
|
